IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
Bailey, Clifford J.1; Aschner, Pablo2; Del Prato, Stefano3; LaSalle, James4; Ji, Linong5; Matthaei, Stephan6; Global Partnership Effective Diabe
关键词Glycaemic Targets Hba(1c) Type 2 Diabetes Individualized Therapy Global Partnership
刊名DIABETES & VASCULAR DISEASE RESEARCH
2013-09-01
DOI10.1177/1479164113490765
10期:5页:397-409
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Endocrinology & Metabolism ; Peripheral Vascular Disease
研究领域[WOS]Endocrinology & Metabolism ; Cardiovascular System & Cardiology
关键词[WOS]BLOOD-GLUCOSE CONTROL ; CARDIOVASCULAR OUTCOMES ; SEVERE HYPOGLYCEMIA ; ORAL MEDICATIONS ; FOLLOW-UP ; MELLITUS ; MANAGEMENT ; RECOMMENDATIONS ; THERAPY ; RISK
英文摘要

The Global Partnership for Effective Diabetes Management, established to provide practical guidance to improve patient outcomes in diabetes, has developed and modified recommendations to improve glycaemic control in type 2 diabetes. The Global Partnership advocates an individualized therapeutic approach and, as part of the process to customize therapy, has previously identified specific type 2 diabetes patient subgroups that require special consideration. This article builds on earlier publications, expanding the scope of practical guidance to include newly diagnosed individuals with complications and women with diabetes in pregnancy. Good glycaemic control remains the cornerstone of managing type 2 diabetes, and plays a vital role in preventing or delaying the onset and progression of diabetic complications. Individualizing therapeutic goals and treatments to meet glycaemic targets safely and without delay remains paramount, in addition to a wider programme of care to reduce cardiovascular risk factors and improve patient outcomes.

语种英语
WOS记录号WOS:000323113600002
资助机构Bristol-Myers Squibb ; AstraZeneca LP ; Novartis Pharma AG
引用统计
被引频次:17[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56809
专题北京大学第二临床医学院
作者单位1.Diabet Zentrum Quakenbruck, Quakenbruck, Germany
2.Univ Pisa, Sch Med, I-56100 Pisa, Italy
3.Med Arts Res Collaborat, Excelsior Springs, MO USA
4.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
5.Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
6.Javeriana Univ, Endocrinol Unit, Sch Med, Bogota, Colombia
推荐引用方式
GB/T 7714
Bailey, Clifford J.,Aschner, Pablo,Del Prato, Stefano,et al. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes[J]. DIABETES & VASCULAR DISEASE RESEARCH,2013,10(5):397-409.
APA Bailey, Clifford J..,Aschner, Pablo.,Del Prato, Stefano.,LaSalle, James.,Ji, Linong.,...&Global Partnership Effective Diabe.(2013).Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.DIABETES & VASCULAR DISEASE RESEARCH,10(5),397-409.
MLA Bailey, Clifford J.,et al."Individualized glycaemic targets and pharmacotherapy in type 2 diabetes".DIABETES & VASCULAR DISEASE RESEARCH 10.5(2013):397-409.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bailey, Clifford J.]的文章
[Aschner, Pablo]的文章
[Del Prato, Stefano]的文章
百度学术
百度学术中相似的文章
[Bailey, Clifford J.]的文章
[Aschner, Pablo]的文章
[Del Prato, Stefano]的文章
必应学术
必应学术中相似的文章
[Bailey, Clifford J.]的文章
[Aschner, Pablo]的文章
[Del Prato, Stefano]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。